Premium
Potassium iodide in refractory, recurrent pediatric Sweet syndrome: Guidance in dosing and monitoring
Author(s) -
Tangtatco Jennifer Aileen Ang,
Ho Nhung,
Drucker Aaron,
Forse Catherine
Publication year - 2018
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.13391
Subject(s) - medicine , refractory (planetary science) , dosing , iodide , potassium , pediatrics , chemistry , inorganic chemistry , physics , organic chemistry , astrobiology
We describe a 5‐month‐old boy with clinical and histopathologic presentation of Sweet syndrome. He responded to systemic corticosteroids, with multiple flares on tapering; potassium iodide was added, which provided complete resolution of Sweet syndrome. Potassium iodide has been used in only a few cases, and no standard dosage has been established in children. We discuss calculation of a pediatric dosage for potassium iodide in Sweet syndrome.